These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 2924514)

  • 1. Pindolol, not verapamil, in combination with digoxin is the treatment of choice in chronic atrial fibrillation.
    Channer KS; James M
    Clin Sci (Lond); 1989 Feb; 76(2):229-30. PubMed ID: 2924514
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved control of atrial fibrillation with combined pindolol and digoxin therapy.
    James MA; Channer KS; Papouchado M; Rees JR
    Eur Heart J; 1989 Jan; 10(1):83-90. PubMed ID: 2702970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative efficacy of oral verapamil and digoxin alone and in combination for the treatment of patients with chronic atrial fibrillation.
    Pomfret SM; Beasley CR; Challenor V; Holgate ST
    Clin Sci (Lond); 1988 Apr; 74(4):351-7. PubMed ID: 3281786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of oral verapamil in controlling ventricular rate in patients with chronic atrial fibrillation receiving digoxin.
    Manoharan S; Kaul UA; Khalilullah M
    J Assoc Physicians India; 1986 Apr; 34(4):257-9. PubMed ID: 3759820
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and chronic pharmacodynamic interaction of verapamil and digoxin in atrial fibrillation.
    Schwartz JB; Keefe D; Kates RE; Kirsten E; Harrison DC
    Circulation; 1982 Jun; 65(6):1163-70. PubMed ID: 7074776
    [No Abstract]   [Full Text] [Related]  

  • 6. Superiority of oral verapamil therapy to digoxin in treatment of chronic atrial fibrillation.
    Lang R; Klein HO; Weiss E; David D; Sareli P; Levy A; Guerrero J; Di Segni E; Kaplinsky E
    Chest; 1983 Mar; 83(3):491-9. PubMed ID: 6337787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of patients with chronic atrial fibrillation.
    Salhadin P; Bran M; De Marneffe M; Denolin H
    Br J Clin Pharmacol; 1982; 13(Suppl 2):295S-296S. PubMed ID: 7104150
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of chronic atrial fibrillation in the elderly, assessed by ambulatory electrocardiographic monitoring.
    Wang R; Camm J; Ward D; Washington H; Martin A
    J Am Geriatr Soc; 1980 Dec; 28(12):529-34. PubMed ID: 7430528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-adrenoceptor blockers in atrial fibrillation: the importance of partial agonist activity.
    Channer KS; James MA; MacConnell T; Rees JR
    Br J Clin Pharmacol; 1994 Jan; 37(1):53-7. PubMed ID: 7908532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of verapamil-quinidine versus digoxin-quinidine in the emergency department treatment of paroxysmal atrial fibrillation.
    Innes GD; Vertesi L; Dillon EC; Metcalfe C
    Ann Emerg Med; 1997 Jan; 29(1):126-34. PubMed ID: 8998091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Towards improved control of atrial fibrillation.
    Channer KS; Papouchado M; James MA; Pitcher DW; Rees JR
    Eur Heart J; 1987 Feb; 8(2):141-7. PubMed ID: 3552679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of digoxin, propranolol, and verapamil on exercise in patients with chronic isolated atrial fibrillation.
    Matsuda M; Matsuda Y; Yamagishi T; Takahashi T; Haraguchi M; Tada T; Kusukawa R
    Cardiovasc Res; 1991 Jun; 25(6):453-7. PubMed ID: 1889058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of verapamil and digoxin in the treatment of atrial fibrillation.
    Lewis R; Lakhani M; Moreland TA; McDevitt DG
    Eur Heart J; 1987 Feb; 8(2):148-53. PubMed ID: 3552680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved rate control in atrial fibrillation.
    Reiffel JA
    Am Heart J; 1992 Apr; 123(4 Pt 1):1094-8. PubMed ID: 1549987
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents.
    Cargnelli G; Domeneghetti F; Ferrari M; Malacini P; Roberti G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):384-8. PubMed ID: 892956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beneficial effects of verapamil in chronic atrial fibrillation.
    Klein HO; Pauzner H; Di Segni E; David D; Kaplinsky E
    Arch Intern Med; 1979 Jul; 139(7):747-9. PubMed ID: 454060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The chronotropic and hemodynamic effects of finoptin in patients with a permanent form of atrial fibrillation].
    Dobrotvorskaia TE; Kazakevich EV; Kuznetsova LA; Kotlov AP
    Ter Arkh; 1992; 64(8):34-6. PubMed ID: 1440391
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparative efficacy of Univer and conventional verapamil in the control of ventricular response in atrial fibrillation.
    Hogg KJ; Hornung RS; Hillis WS
    Br J Clin Pract Suppl; 1988 Apr; 60():38-44. PubMed ID: 3151270
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
    Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
    Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationships between heart rate, exercise tolerance and cardiac output in atrial fibrillation: the effects of treatment with digoxin, verapamil and diltiazem.
    Lewis RV; Irvine N; McDevitt DG
    Eur Heart J; 1988 Jul; 9(7):777-81. PubMed ID: 3169046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.